Skip to main content
Log in

Lack of cross-resistance between imipenem and other beta-lactam antibiotics forPseudomonas aeruginosa

  • Letters to the Editor
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Brown, K. R.: Eine aktuelle Übersicht über die weltweit vorliegenden klinischen Erfahrungen mit Imipenem/ Cilastatin. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1986, 5: 415–418.

    Google Scholar 

  2. Jones, R. N.: Review of the in vitro spectrum of activity of imipenem. American Journal of Medicine 1985, 78, Supplement 6A: 22–32.

    Article  Google Scholar 

  3. Sanders, C., Sanders, W. E.: Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 1983, 5: 639–648.

    PubMed  Google Scholar 

  4. Salata, R. A., Gebhart, R. L., Palmer, D. L., Wade, B. H., Scheld, W. M., Groschel, D. H. M., Wenzel, R. P., Mandell, G. L., Duma, R. J.: Pneumonia treated with imipenem/cilastatin. Journal of the American Medical Association 1985, 78, Supplement 6A: 96–102.

    Google Scholar 

  5. Pedersen, S. S., Pressler, T., Høiby, N., Bentzon, M. W., Koch, C.: Imipenem/cilastatin treatment of multi-resistantPseudomonas aeruginosa lung infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy 1985, 16: 629–635.

    PubMed  Google Scholar 

  6. Curtis, N. A., Eisenstadt, R. L., Rudd, C., White, A. J.: Induciblc type Iβ-lactamases of gram-negative bacteria and resistance toβ-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 17: 51–61.

    PubMed  Google Scholar 

  7. Yoshimura, F., Nikaido, H.: Diffusion ofβ-lactam antibiotics through the porin channels ofEscherichia coli K-12. Antimicrobial Agents and Chemotherapy 1985, 27: 84–92.

    PubMed  Google Scholar 

  8. Thabaut, A., Philippon, A., Meyran, M.: Activité comparée des β-lactamines actives surPseudomonas aeruginosa en fonction des phénotypes de résistance. Presse Médicale 1984: 768–771.

  9. Cullmann, W., Büscher, K. H., Operkuch, W., Dick, W.: Häufigkeit und Ursachen der Resistenz gramnegativer Keime gegenüber Imipenem. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie 1986, 5: 249–260.

    Google Scholar 

  10. Quinn, J. P., Dudek, E. J., Divincenzo, C. A., Lucks, D. A., Lerner, S. A.: Emergence of resistance to imipenem during therapy forPseudomonas aeruginosa infections. Journal of Infectious Diseases 1986, 154: 289–294.

    PubMed  Google Scholar 

  11. Büscher, K. H., Cullmann, W., Dick, W., Opferkuch, W.: Imipenem resistance inPseudomonas aeruginosa is due to a diminished expression of an outer membrane protein. Antimicrobial Agents and Chemotherapy 1987, 31: 703–708.

    PubMed  Google Scholar 

  12. Krech, T., Naumann, P.: Resistenzentwicklungen unter Imipenem-Therapie beiPseudomonas aeruginosa. Immunität und Infektion 1986, 14: 224–226.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opferkuch, W., Cullmann, W. Lack of cross-resistance between imipenem and other beta-lactam antibiotics forPseudomonas aeruginosa . Eur. J. Clin. Microbiol. 6, 330–332 (1987). https://doi.org/10.1007/BF02017634

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02017634

Keywords

Navigation